Wu W - Search Results

1

Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.

Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Wu W, et al. Clin Exp Metastasis. 2002;19(4):319-26. doi: 10.1023/a:1015515119300. Clin Exp Metastasis. 2002. PMID: 12090472

2

Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.

Chang YS, Wu W, Walsh G, Hong WK, Mao L. Chang YS, et al. Among authors: wu w. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3641-4. Clin Cancer Res. 2003. PMID: 14506152

3

Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.

Hu W, Wu W, Verschraegen CF, Chen L, Mao L, Yeung SC, Kudelka AP, Freedman RS, Kavanagh JJ. Hu W, et al. Among authors: wu w. Proteomics. 2003 Oct;3(10):1904-11. doi: 10.1002/pmic.200300547. Proteomics. 2003. PMID: 14625852

4

Proteomics in cancer screening and management in gynecologic cancer.

Hu W, Wu W, Kobayashi R, Kavanagh JJ. Hu W, et al. Among authors: wu w. Curr Oncol Rep. 2004 Nov;6(6):456-62. doi: 10.1007/s11912-004-0076-4. Curr Oncol Rep. 2004. PMID: 15485615 Review.

5

Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.

Tang X, Wu W, Sun SY, Wistuba II, Hong WK, Mao L. Tang X, et al. Among authors: wu w. Mol Cancer Res. 2004 Dec;2(12):685-91. Mol Cancer Res. 2004. PMID: 15634757

6

Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.

Hu W, Wu W, Yeung SC, Freedman RS, Kavanagh JJ, Verschraegen CF. Hu W, et al. Among authors: wu w. Anticancer Res. 2002 Mar-Apr;22(2A):665-72. Anticancer Res. 2002. PMID: 12014635

7

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.

Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: wu w. J Clin Oncol. 2004 Aug 1;22(15):3126-32. doi: 10.1200/JCO.2004.11.154. J Clin Oncol. 2004. PMID: 15284264

8

Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.

Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH. Oh JC, et al. Among authors: wu w. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):748-52. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159305

9

Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.

Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH. Wu W, et al. Cancer Res. 2003 Oct 1;63(19):6195-9. Cancer Res. 2003. PMID: 14559803

10

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: wu w. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,193 results

Search Page

Filters